Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

J Yong, JD Johnson, P Arvan, J Han… - Nature Reviews …, 2021 - nature.com
Diabetes mellitus is characterized by the failure of insulin-secreting pancreatic β-cells (or β-
cell death) due to either autoimmunity (type 1 diabetes mellitus) or failure to compensate for …

Living dangerously: protective and harmful ER stress responses in pancreatic β-cells

RB Sharma, HV Landa-Galván, LC Alonso - Diabetes, 2021 - Am Diabetes Assoc
Type 2 diabetes (T2D) is a growing cause of poor health, psychosocial burden, and
economic costs worldwide. The pancreatic β-cell is a cornerstone of metabolic physiology …

[HTML][HTML] ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

SAW Greeley, M Polak, PR Njølstad, F Barbetti… - Pediatric …, 2022 - ncbi.nlm.nih.gov
ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of
monogenic diabetes in children and adolescents - PMC Back to Top Skip to main content NIH …

[HTML][HTML] Current drug repurposing strategies for rare neurodegenerative disorders

S Shah, MM Dooms, S Amaral-Garcia… - Frontiers in …, 2021 - frontiersin.org
Rare diseases are life-threatening or chronically debilitating low-prevalent disorders caused
by pathogenic mutations or particular environmental insults. Due to their high complexity …

[HTML][HTML] Loss of function of WFS1 causes ER stress-mediated inflammation in pancreatic beta-cells

S Morikawa, L Blacher, C Onwumere… - Frontiers in …, 2022 - frontiersin.org
Wolfram syndrome is a rare genetic disorder characterized by juvenile-onset diabetes
mellitus, optic nerve atrophy, hearing loss, diabetes insipidus, and progressive …

[HTML][HTML] Dysregulated Ca2+ Homeostasis as a Central Theme in Neurodegeneration: Lessons from Alzheimer's Disease and Wolfram Syndrome

M Callens, J Loncke, G Bultynck - Cells, 2022 - mdpi.com
Calcium ions (Ca2+) operate as important messengers in the cell, indispensable for
signaling the underlying numerous cellular processes in all of the cell types in the human …

[HTML][HTML] Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome

RA Kitamura, KG Maxwell, W Ye, K Kries, CM Brown… - JCI insight, 2022 - ncbi.nlm.nih.gov
Wolfram syndrome is a rare genetic disorder largely caused by pathogenic variants in the
WFS1 gene and manifested by diabetes mellitus, optic nerve atrophy, and progressive …

[HTML][HTML] GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models

V Gorgogietas, B Rajaei, C Heeyoung, BJ Santacreu… - Diabetologia, 2023 - Springer
Aims/hypothesis Wolfram syndrome is a rare autosomal recessive disorder caused by
pathogenic variants in the WFS1 gene. It is characterised by insulin-dependent diabetes …

Exploring antidiabetic potential of a polyherbal formulation Madhurakshak Activ: An in vitro and in silico study

S Paul, M Majumdar - Fitoterapia, 2023 - Elsevier
Madhurakshak Activ (MA), a commercial polyherbal antidiabetic preparation is known to
manage diabetes mellitus (DM) by reducing blood glucose levels. However, lacks …

[HTML][HTML] NCS1 overexpression restored mitochondrial activity and behavioral alterations in a zebrafish model of Wolfram syndrome

L Crouzier, EM Richard, C Diez, M Denus… - … Therapy-Methods & …, 2022 - cell.com
Wolfram syndrome (WS) is a rare neurodegenerative disease resulting in deafness, optic
atrophy, diabetes, and neurological disorders. Currently, no treatment is available for …